Beaird Harris Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Beaird Harris Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$112K	Sell	224 -1	-0.4%	-$480	0.01%	201
2026 Q1	$110K	Hold	225	–	–	0.01%	178
2025 Q4	$130K	Hold	225	–	–	0.01%	165
2025 Q3	$109K	Buy	225 +1	+0.4%	+$465	0.01%	172
2025 Q2	$90.8K	Hold	224	–	–	0.01%	191
2025 Q1	$111K	Hold	224	–	–	0.01%	159
2024 Q4	$117K	Hold	224	–	–	0.01%	161
2024 Q3	$139K	Buy	224 +199	+796%	+$118K	0.01%	155
2024 Q2	$13.6K	Sell	25 -11	-31%	-$6.3K	﹤0.01%	342
2024 Q1	$20.9K	Sell	36 -9	-20%	-$5.05K	﹤0.01%	274
2023 Q4	$23.9K	Buy	45 +31	+221%	+$15K	﹤0.01%	247
2023 Q3	$7.09K	Hold	14	–	–	﹤0.01%	285
2023 Q2	$7.3K	Hold	14	–	–	﹤0.01%	288
2023 Q1	$8.07K	Sell	14 -9	-39%	-$5.07K	﹤0.01%	286
2022 Q4	$12.7K	Buy	23 +9	+64%	+$4.77K	﹤0.01%	301
2022 Q3	$7K	Hold	14	–	–	﹤0.01%	318
2022 Q2	$8K	Sell	14 -209	-94%	-$115K	﹤0.01%	270
2022 Q1	$132K	Buy	223 +9	+4%	+$5.17K	0.05%	107
2021 Q4	$143K	Buy	+214	New	+$134K	0.05%	131

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Beaird Harris Wealth Management's TMO Position: Q2 2026 in Review

Beaird Harris Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 0.44% in Q2 2026, selling an estimated $480 and leaving 224 shares worth $112K. The position accounts for 0.01% of the portfolio, ranked #201.

Beaird Harris Wealth Management first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $143K in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Beaird Harris Wealth Management held 224 shares of Thermo Fisher Scientific worth $112K as of Q2 2026.
Beaird Harris Wealth Management sold 1 Thermo Fisher Scientific share in Q2 2026, an estimated $480.
Thermo Fisher Scientific made up 0.01% of Beaird Harris Wealth Management's portfolio in Q2 2026, its #201 holding.
Beaird Harris Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
Beaird Harris Wealth Management's Thermo Fisher Scientific position peaked at $143K in Q4 2021.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Beaird Harris Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.